RecruitMe Clinical Trial

Investigation of the NMDA Antagonist Ketamine as a Treatment for Tinnitus
Research on Ketamine for Tinnitus (Ringing in the Ears)
Sponsor:Department of Defense
Enrolling:Male and Female Patients
Study Length:28 Days
Clinic Visits:4
Age Range:Between 21 and 65 years old
IRB Number:7432
U.S. Government ID:NCT03336398
Contact: Diana Martinez, MD: 646-774-7654 / dm437@cumc.columbia.edu
Additional Study Information:

This research study is investigating ketamine as a possible treatment for tinnitus or ringing in the ears. Ketamine is FDA approved for anesthesia and depression that doesn't respond to regular antidepressants. It is not approved for tinnitus. This study involves two scans using magnetic resonance imaging (MRI). Each of the scans last one and a half hours each. Ketamine is administered during one of the scans. The study also involves three audiological appointments, each lasting one hour, to measure tinnitus symptoms. Compensation for time and travel are provided. Contact (646) 774 7654 for more information.

Do You Qualify?
Do you suffer from tinnitus (ringing in your ears)?YesNo
Submit
Cancel
Investigator
Diana Martinez, MD
You may be eligible for this study

Place Holder




Who Can I Contact?
For more information, please contact:
Diana Martinez, MD
Email: dm437@cumc.columbia.edu
Phone: 646-774-7654